Stock research, congress trades and insider data
Built on SEC 13F and Form 4 filings and House trade disclosures, with Alpha Scores, weekly briefings and public portfolios on TipRanks. 15+ years in markets.
Ask AlphaScala
NEWQQQ fell 3.04% to 690.56 for the week, 1.78 percentage points worse than SPY's 1.26% decline. NVDA was the weakest heavyweight in the latest session at 204.64, down 4.22%, with MSFT off 1.55% and AAPL 1.23% lower. Pete Sessions disclosed six technology sales in a periodic transaction report, five of them dated Oct. 2. AlphaScala's Alpha Scores for the six largest constituents, last updated Oct. 28, range from 49 to 60.
Read full briefingS&P 500 slips 1.3% as QQQ sheds 3%; Sessions discloses $1.1M in tech sales
Bitcoin at $78,297; QQQ down 3.04% for the week
Ethereum edges up 1.06% as SPY, QQQ slide over week
Gold edges up 0.66% as equities slide; Tether Fund lifts Gold.com stake
Oil quiet as supply catalysts absent; Nasdaq drops 3.04%
Sterling gains 0.3% as dollar flat; COT shows heavy euro shorts, yen longs
Filings data, updated from the source
| COIN | PRICE | CHG | %CHG |
|---|---|---|---|
| LINK | 11.17 | +0.04 | +0.34 ▲ |
| LTC | 54.49 | +0.77 | +1.43 ▲ |
| XRP | 1.2769 | +0.0267 | +2.14 ▲ |
| DOT | 0.94 | +0.0030 | +0.32 ▲ |
| DOGE | 0.0752 | +0.0010 | +1.32 ▲ |
| AVAX | 8.595 | +0.2010 | +2.39 ▲ |
| SOL | 93.40 | +1.42 | +1.54 ▲ |
| ADA | 0.1906 | +0.0020 | +1.06 ▲ |
| BTC | 77,394.01 | +578.01 | +0.75 ▲ |
| ETH | 2,287.46 | +34.17 | +1.52 ▲ |
| PAIR | BID | CHG | %CHG |
|---|---|---|---|
| EUR/GBP | 0.8337 | -0.0010 | -0.12 ▼ |
| EUR/JPY | 177.25 | +0.46 | +0.26 ▲ |
| GBP/JPY | 212.59 | +0.81 | +0.38 ▲ |
| GBP/USD | 1.3433 | +0.0022 | +0.16 ▲ |
| USD/CHF | 0.82 | +0.0017 | +0.21 ▲ |
| TICKER | PRICE | CHG | %CHG |
|---|---|---|---|
| WMT | 127.69 | +4.18 | +3.38 ▲ |
| V | 425.51 | +11.92 | +2.88 ▲ |
| JPM | 340.58 | +3.54 | +1.05 ▲ |
| TSLA | 403.82 | +4.01 | +1.00 ▲ |
| META | 606.73 | -8.26 | -1.34 ▼ |
Latest Analysis
View AllAlphaScala Updates
Top market moves, trading setups, broker insights. Free, no spam.